Fidelity Investments’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7 | Sell |
6
-227
| -97% | -$265 | ﹤0.01% | 5296 |
|
|
2025
Q1 | $294 | Buy |
233
+122
| +110% | +$154 | ﹤0.01% | 5060 |
|
|
2024
Q4 | $252 | Buy |
+111
| New | +$252 | ﹤0.01% | 5039 |
|
|
2024
Q1 | – | Sell |
-8
| Closed | -$35 | – | 5363 |
|
|
2023
Q4 | $35 | Buy |
+8
| New | +$35 | ﹤0.01% | 5083 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5284 |
|
|
2023
Q2 | – | Sell |
-27
| Closed | -$1.32K | – | 5380 |
|
|
2023
Q1 | $1.32K | Buy |
+27
| New | +$1.32K | ﹤0.01% | 4703 |
|
|
2022
Q4 | – | Sell |
-2
| Closed | – | – | 5352 |
|
|
2022
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 4849 |
|
|
2022
Q2 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4912 |
|
|
2021
Q4 | – | Sell |
-44
| Closed | -$2K | – | 4331 |
|
|
2021
Q3 | $2K | Buy |
+44
| New | +$2K | ﹤0.01% | 3979 |
|
|
2021
Q1 | – | Sell |
-47
| Closed | -$3K | – | 3972 |
|
|
2020
Q4 | $3K | Hold |
47
| – | – | ﹤0.01% | 3509 |
|
|
2020
Q3 | $12K | Sell |
47
-28
| -37% | -$7.15K | ﹤0.01% | 3149 |
|
|
2020
Q2 | $13K | Sell |
75
-16
| -18% | -$2.77K | ﹤0.01% | 3065 |
|
|
2020
Q1 | $6K | Sell |
91
-4
| -4% | -$264 | ﹤0.01% | 3206 |
|
|
2019
Q4 | $6K | Sell |
95
-89
| -48% | -$5.62K | ﹤0.01% | 3355 |
|
|
2019
Q3 | $11K | Buy |
+184
| New | +$11K | ﹤0.01% | 3203 |
|